$TBPH Theravance Biopharma, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Theravance Biopharma, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Theravance Biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Theravance Biopharma, Inc. for free.

CIK Number: 0001583107
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TBPH
Company Address: UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN KY1-1104

Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Market Capitalization: $1.64B
Prev close: $30.60
Average Daily Volume: 346,635
Days Low: $30.63
Year Low: $13.59
Year High: $38.92

Theravance Biopharma, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BROSHY ERANDirector26,186801,292shares bought: 20,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago
GALA RENEE DSVP, Chief Financial Officer246,0227,528,273shares bought: 132,750 / shares sold: -48,123 STRONG BUYMay 16 20184 days ago
Gunderson Robert V JRDirector43,2451,323,297shares bought: 20,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc175,9535,384,162shares bought: 132,750 / shares sold: -87,305 BUYMay 16 20184 days ago
HEGDE SHARATHCHANDRA SSVP, Research193,3615,916,847shares bought: 147,750 / shares sold: -35,554 STRONG BUYMay 16 20184 days ago
MALKIEL BURTON GDirector55,7571,706,164shares bought: 50,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago
MITCHELL DEAN JDirector26,186801,292shares bought: 20,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago
Molineaux SusanDirector14,186434,092shares bought: 20,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago
O'Connor DonalDirector23,186709,492shares bought: 20,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago
PASQUALONE FRANKSVP, Chief Comm Ops Officer246,2347,534,760shares bought: 136,750 / shares sold: -30,963 STRONG BUYMay 16 20184 days ago
PITZER KENNETH RSVP, Prod Strat & Comm Plng185,8045,685,602shares bought: 156,750 / shares sold: -34,507 STRONG BUYMay 16 20184 days ago
RINGROSE PETER SDirector29,614906,188shares bought: 20,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago
Shafer Bradford JEVP, Gen. Counsel, Secretary165,2765,057,446shares bought: 166,750 / shares sold: -141,909 BUYMay 16 20184 days ago
Smaldone Alsup LaurieDirector9,962304,837shares bought: 9,962 / shares sold: 0 STRONG BUYMay 03 201817 days ago
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy101,2303,097,638shares bought: 110,000 / shares sold: -8,770 STRONG BUYFeb 22 20183 months ago
WHITESIDES GEORGE MDirector192,5785,892,887shares bought: 24,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago
Winningham Rick EChief Executive Officer987,23730,209,452shares bought: 451,000 / shares sold: -70,089 STRONG BUYMay 16 20184 days ago
WORBOYS PHILIP DSVP, Translational Science198,1786,064,247shares bought: 156,750 / shares sold: -37,784 STRONG BUYMay 16 20184 days ago
YOUNG WILLIAM DDirector43,3101,325,286shares bought: 20,186 / shares sold: 0 STRONG BUYMay 03 201817 days ago

View all Theravance Biopharma, Inc. insiders.

Theravance Biopharma, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 16 2018TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...GrantA0.0033,7500198,178164.4 K to 198.2 K (+20.53 %)
May 16 2018TBPHTheravance Biophar ...Winningham Rick EChief Executive Off ...GrantA0.00105,0000987,237882.2 K to 987.2 K (+11.90 %)
May 16 2018TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...GrantA0.0033,7500165,276131.5 K to 165.3 K (+25.66 %)
May 16 2018TBPHTheravance Biophar ...PITZER KENNETH RSVP, Prod Strat & C ...GrantA0.0033,7500185,804152.1 K to 185.8 K (+22.20 %)
May 16 2018TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...GrantA0.0033,7500246,234212.5 K to 246.2 K (+15.88 %)
May 16 2018TBPHTheravance Biophar ...HEGDE SHARATHCHANDRA SSVP, ResearchGrantA0.0033,7500193,361159.6 K to 193.4 K (+21.15 %)
May 16 2018TBPHTheravance Biophar ...HAUMANN BRETT KSVP Clin Dev & Chie ...GrantA0.0033,7500175,953142.2 K to 176 K (+23.73 %)
May 16 2018TBPHTheravance Biophar ...GALA RENEE DSVP, Chief Financia ...GrantA0.0033,7500246,022212.3 K to 246 K (+15.90 %)
May 03 2018TBPHTheravance Biophar ...YOUNG WILLIAM DDirectorOption ExerciseA24.436,000146,5806,000
May 03 2018TBPHTheravance Biophar ...YOUNG WILLIAM DDirectorGrantA0.008,186043,31035.1 K to 43.3 K (+23.31 %)
May 03 2018TBPHTheravance Biophar ...WHITESIDES GEORGE MDirectorOption ExerciseA24.436,000146,5806,000
May 03 2018TBPHTheravance Biophar ...WHITESIDES GEORGE MDirectorGrantA0.008,1860192,578184.4 K to 192.6 K (+4.44 %)
May 03 2018TBPHTheravance Biophar ...Smaldone Alsup LaurieDirectorOption ExerciseA24.436,000146,5806,000
May 03 2018TBPHTheravance Biophar ...Smaldone Alsup LaurieDirectorGrantA0.008,18609,9621.8 K to 10 K (+460.92 %)
May 03 2018TBPHTheravance Biophar ...RINGROSE PETER SDirectorOption ExerciseA24.436,000146,5806,000

View all Theravance Biopharma, Inc. insider transactions.